TetraGenetics' Grant - III Round

TetraGenetics raised a round of funding on January 14, 2016. Investors include National Institute of General Medical Sciences.

Tetragenetics is an early-stage biotechnology company meeting the needs of customers who seek a cost-effective alternative platform technology for the production of genetically engineered proteins. Th…

Articles about TetraGenetics' Grant - III Round: